{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:50:23Z","timestamp":1785793823161,"version":"3.56.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aimed to compare fecal calprotectin (FC) levels with other commonly used parameters as part of patient care during evaluation for inflammatory bowel disease (IBD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We recruited adult IBD patients with ulcerative colitis (UC) and Crohn\u2019s disease (CD) and compared the results of the patient\u2019s biopsy results (i.e., inflamed versus noninflamed) for six sites (i.e., ileum, ascending colon, transverse colon, descending colon, sigmoid colon, rectum) with concentrations of C-reactive protein (CRP), total leucocytes and fecal calprotectin (FC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found that FC was significantly elevated in a concentration-dependent manner that correlated with the number of active inflammation sites reported in biopsy. Although CRP and leucocyte measurements trended upwards in line with inflammation reported from biopsy, the results were highly variable and highlighted poor reliability of these biomarkers for indicating IBD inflammation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results strongly suggest that FC correlates best with biopsy reports and is a superior marker than CRP and leucocytes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jcag\/gwaa009","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T20:14:39Z","timestamp":1582661679000},"page":"84-90","source":"Crossref","is-referenced-by-count":30,"title":["Fecal Calprotectin, CRP and Leucocytes in IBD Patients: Comparison of Biomarkers With Biopsy Results"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4304-5762","authenticated-orcid":false,"given":"Barry D","family":"Kyle","sequence":"first","affiliation":[{"name":"DynaLIFE Medical Labs, Edmonton, Alberta, Canada"},{"name":"Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"},{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence A","family":"Agbor","sequence":"additional","affiliation":[{"name":"DynaLIFE Medical Labs, Edmonton, Alberta, Canada"},{"name":"Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada"},{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shajib","family":"Sharif","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita L S","family":"Halder","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ip","sequence":"additional","affiliation":[{"name":"Grey Nuns Hospital, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6282-9514","authenticated-orcid":false,"given":"Waliul I","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"},{"name":"Hamilton Health Sciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"issue":"2","key":"2021040620034958100_CIT0001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/gastro\/goy006","article-title":"Role of endoscopy in inflammatory bowel disease","volume":"6","author":"Bharadwaj","year":"2018","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"5","key":"2021040620034958100_CIT0002","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/00365521.2017.1401116","article-title":"Systematic review: Advice lines for patients with inflammatory bowel disease","volume":"53","author":"Bager","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"2021040620034958100_CIT0003","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ibd\/izy015","article-title":"Quality of life in inflammatory bowel disease: A systematic review and meta-analyses-part II","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2021040620034958100_CIT0004","doi-asserted-by":"crossref","first-page":"101602","DOI":"10.1016\/j.bpg.2019.02.004","article-title":"What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn\u2019s disease activity?","volume":"38\u201339","author":"Ma","year":"2019","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2021040620034958100_CIT0005","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MCG.0000000000001244","article-title":"Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy","volume":"53","author":"Tandon","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"2021040620034958100_CIT0006","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/MEG.0000000000001284","article-title":"Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"30","author":"Verdejo","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"2021040620034958100_CIT0007","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10620-014-3362-5","article-title":"Hematologic indices as surrogate markers for monitoring thiopurine therapy in IBD","volume":"60","author":"Kopylov","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"4","key":"2021040620034958100_CIT0008","first-page":"304","article-title":"Therapeutic drug monitoring in inflammatory bowel disease","volume":"27","author":"Kopylov","year":"2014","journal-title":"Ann Gastroenterol"},{"key":"2021040620034958100_CIT0009","first-page":"2708909","article-title":"Upper gastrointestinal Crohn\u2019s disease: Literature review and case presentation","volume":"2019","author":"Aggarwal","year":"2019","journal-title":"Case Rep Gastrointest Med"},{"key":"2021040620034958100_CIT0010","doi-asserted-by":"crossref","first-page":"101202","DOI":"10.1016\/j.redox.2019.101202","article-title":"Oxidative cross-linking of calprotectin occurs in vivo, altering its structure and susceptibility to proteolysis","volume":"24","author":"Hoskin","year":"2019","journal-title":"Redox Biol"},{"issue":"6","key":"2021040620034958100_CIT0011","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1248\/bpb.26.753","article-title":"Calprotectin (S100A8\/S100A9), an inflammatory protein complex from neutrophils with a broad apoptosis-inducing activity","volume":"26","author":"Yui","year":"2003","journal-title":"Biol Pharm Bull"},{"key":"2021040620034958100_CIT0012","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: Diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"issue":"36","key":"2021040620034958100_CIT0013","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.3748\/wjg.v22.i36.8211","article-title":"FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease","volume":"22","author":"Rosenfeld","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2021040620034958100_CIT0014","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/0300060513488499","article-title":"Faecal calprotectin concentrations in gastrointestinal diseases","volume":"41","author":"Wang","year":"2013","journal-title":"J Int Med Res"},{"issue":"3","key":"2021040620034958100_CIT0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.45.3.362","article-title":"High prevalence of NSAID enteropathy as shown by a simple faecal test","volume":"45","author":"Tibble","year":"1999","journal-title":"Gut"},{"issue":"1","key":"2021040620034958100_CIT0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15171\/mejdd.2018.123","article-title":"Clinical and pathological features of ulcerative colitis in patients with and without Clostridium difficile infection; An observational study","volume":"11","author":"Aletaha","year":"2018","journal-title":"Middle East J Dig Dis"},{"issue":"5","key":"2021040620034958100_CIT0017","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-016-1182-4","article-title":"Fecal calprotectin: Its scope and utility in the management of inflammatory bowel disease","volume":"51","author":"Ikhtaire","year":"2016","journal-title":"J Gastroenterol"},{"key":"2021040620034958100_CIT0018","doi-asserted-by":"crossref","first-page":"1450970","DOI":"10.1155\/2017\/1450970","article-title":"Comparison of fecal calprotectin methods for predicting relapse of pediatric inflammatory bowel disease","volume":"2017","author":"Kittanakom","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"2021040620034958100_CIT0019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2478\/folmed-2018-0071","article-title":"Role of fecal calprotectin as a noninvasive indicator for ulcerative colitis disease activity","volume":"61","author":"Nakov","year":"2019","journal-title":"Folia Med (Plovdiv)"},{"issue":"3","key":"2021040620034958100_CIT0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3164\/jcbn.18-92","article-title":"Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type","volume":"64","author":"Sonoyama","year":"2019","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"2021040620034958100_CIT0021","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-017-1223-2","article-title":"A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis","volume":"19","author":"Klingberg","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"2021040620034958100_CIT0022","first-page":"297","article-title":"Fecal Calprotectin for assessment of inflammatory activity, monitoring of therapy and prediction of relapse in ulcerative colitis","volume":"1","author":"Nakov","year":"2012","journal-title":"J Gastroenterol Hepatol Res"},{"issue":"1","key":"2021040620034958100_CIT0023","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009742.2017.1299216","article-title":"Faecal calprotectin detects subclinical bowel inflammation and may predict treatment response in spondyloarthritis","volume":"47","author":"\u00d8stg\u00e5rd","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"2021040620034958100_CIT0024","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MIB.0000442681.85545.31","article-title":"Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease","volume":"20","author":"Kopylov","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"2021040620034958100_CIT0025","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ecco-jcc\/jjz087","article-title":"Adverse events and nocebo effects in inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Ma","year":"2019","journal-title":"J Crohns Colitis"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/4\/2\/84\/36887782\/gwaa009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcag\/article-pdf\/4\/2\/84\/36887782\/gwaa009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T22:42:41Z","timestamp":1617748961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/4\/2\/84\/5812676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,27]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwaa009","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,3,27]]}}}